BillionToOne, Inc.(BLLN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

BillionToOne, Inc. (BLLN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BLLN at 61.9/100 on a 32-signal composite quality model, placing it at rank #747 of 2,962 stocks — the top half of the AI-ranked universe. BLLN scores in the top quartile across institutional flow (98.1), revenue growth (93.2). Areas of concern include revenue scale (33.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), BillionToOne, Inc. reports quarterly revenue of $109.4M, net income of $8.1M, an operating margin of 5.0%. Top institutional holders of BLLN by reported 13-F value include ADAMS STREET PARTNERS, PRICE T ROWE ASSOCIATES, BAILLIE GIFFORD, based on the most recent SEC filings. BLLN trades on the Nasdaq exchange and files with the SEC under CIK 2070849. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BLLN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BillionToOne, Inc. directly from SEC EDGAR.